ARTICLE | Product Development
Roche latest heavy hitter to scale up serological tests
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
April 18, 2020 12:48 AM UTC
Updated on Apr 19, 2020 at 7:32 PM UTC
COVID-19 serological testing capacity is set to surge as diagnostic giant Roche joins the ranks of companies offering assays to detect antiviral antibodies. The ramp up in volume comes amidst ongoing uncertainty about the accuracy of marketed tests.
On Friday, Roche (SIX:ROG; OTCQX:RHHBY) announced its high-throughput Elecsys Anti-SARS-CoV-2 serology test will be available in countries that accept the EU's CE mark in early May; Roche said it is in the process of seeking FDA Emergency Use Authorization (EUA)...